AMY RUSSO: Open Payments
NPI 1316619901 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$496 in 25 payments from 21 companies in 2025. Trend: 2023 $556 · 2024 $416 · 2025 $496
Food & beverage: $496
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Novo Nordisk Inc | 2 | $37 |
| Lilly USA, LLC | 2 | $31 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
| Astellas Pharma US Inc | 1 | $24 |
| Lundbeck LLC | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Exact Sciences Corporation | 1 | $23 |
| Ferring Pharmaceuticals Inc. | 1 | $23 |
Products named: JARDIANCE, Wegovy, FANAPT, Veozah, REXULTI, CAPLYTA, Cologuard Collection Kit, ADSTILADRIN.
Industry payments across MI — which companies pay providers there.
